The Library of Congress >  Researchers >  Search Finding Aids  >  Frances Oldham Kelsey papers, 1890-2016
Access restrictions apply.Some or all content stored offsite.
ContainerContents
Part II: Speeches and Writings File, 1929-2010 (continued)
BOX II:91 No. 29, 1946-1971, 1984-2002, undated
(3 folders)
BOX II:92 (1 folder)
BOX II:92 Nos. 30-34, 1945, 1951-2001, undated
(7 folders)
BOX II:92 Miscellany, 1948, 1954
BOX II:93 Book reviews, 1950-1959, undated
BOX II:93 Dissertation, 1938
BOX II:93 Editorials, 1951-1959, undated
(3 folders)
BOX II:93 Fragments, undated
BOX II:93 Miscellaneous
BOX II:93 1960-1997
(2 folders)
BOX II:93 Undated
(1 folder)
BOX II:94 (1 folder)
BOX II:94 Queries and Minor Notes/Questions and Answers sections, 1952-1961, undated
BOX II:94 Requests for reprints, 1940-1971, 1981-1992
(4 folders)
BOX II:94 Submission on thalidomide written for the Lyndon Baines Johnson Presidential Library, Austin, Tex., 1968
BOX II:94 By others, articles
BOX II:94 1950-1955
BOX II:95 1960-2000, undated
(6 folders)
BOX II:95-II:210 Part II: Subject File, 1902-2012
Correspondence, memoranda, reports, statements, studies, proposals, reviews, guidelines, reprints of articles, clippings, press releases, testimonies, minutes, printed matter, and microfiche.
Arranged alphabetically by subject, name of person or organization, or type of material and thereunder chronologically.
BOX II:95 Accutane See Containers II:208-II:209, Vitamin D and Vitamin A
BOX II:95 Adverse drug reaction reports, 1963-1966
BOX II:95 Adverse drug reactions, 1972, 1989, 1995-1998
BOX II:96 Advisory Committee on Fertility and Maternal Health Drugs, transcript, 1981
BOX II:96 Advisory Committee on the Teratogenic Effect of Certain Drugs, 1966
BOX II:96 AIDS (Disease), 1981-2000
BOX II:96 Alcohol, fetal alcohol syndrome, and Antabuse (disulfiram), 1932, 1969-1988, 1994-2000, undated
(2 folders)
BOX II:96 Amantadine, 1975
BOX II:96 American Arbitration Association, proposal for ethical review of investigational new drug studies, 1962-1974, 1996, undated
BOX II:96 American Medical Association, 1962-1963, undated
BOX II:97 American Medical Women’s Association, 1967-1972, 1979-1987
BOX II:97 American Medical Writers’ Association, circa 1960-1984, 1990-1999, undated
(3 folders)
BOX II:97 American Revolution Bicentennial Commission, Department of Health, Education and Welfare Committee, 1970-1971
BOX II:97 American Society for Pharmacological and Experimental Therapeutics/Western Pharmacological Society, 1961, 1966-1973, 1979-1980, 1998-1999
BOX II:97 Amino acids for treatment of inborn errors of metabolism, 1970-1972, 1984, undated
BOX II:97 Amniocentesis (intrauterine diagnosis), 1970-1978, 1989-1991, undated
BOX II:97 Amphetamines, 1962-1978, 1986-1991
BOX II:97 Anesthetic agents, 1970-1977, undated
BOX II:97 Animal screening procedures See Containers II:194-II:195, Teratology, screening procedures
BOX II:98 Antihistamines, 1949-1989, 1998-2001, undated
(7 folders)
BOX II:98 Antihypertensives, 1969-1972, 1978-1986, undated
BOX II:98 Antimalarial Program and antimalarial drugs See Containers II:91-II:92, Essentials of Pharmacology, Chapter 29
BOX II:98 Antimetabolites/anticancer, 1954-1985, 1991, undated See also Container II:173, Methotrexate
BOX II:98 Apgar, Virginia, 1960, 1968, 1984-1985, 2000, undated
BOX II:98 Aprindine See Container II:139, Eli Lilly and Co. Task Group
BOX II:98 Archer, John D. See Container II:196, same heading
BOX II:98 Aronow, Wilbert S., investigation
BOX II:98 1979-1982
BOX II:99 1983-1984, 1996-1997
(2 folders)
BOX II:99 Artificial sweeteners
BOX II:99 Aspartame/NutraSweet See Container II:145, same heading
BOX II:99 Cyclamates, 1965-1971, undated
BOX II:99 Saccharin, 1977
BOX II:99 Aspirin See Container II:191, Salicylates
BOX II:99 Asteroids, 1972-1985, 1994-1998
BOX II:99 Ayerst Laboratories, New York, N.Y. See Container II:187, Practolol
BOX II:99 Barbituates, 1972, 1980-1982
BOX II:99 Baycol, 2001
BOX II:99 Behavioral teratology, 1938, 1961-1986, 1992, undated
(4 folders)
BOX II:100 Bendectin, 1962-1999, undated See also Containers II:170-II:171, Maternal-Child Problems Task Force
(5 folders)
BOX II:100 Benoxaprofen (Oraflex), 1983-1988 See also Container II:139, Eli Lilly and Co. Task Group
BOX II:100 Beta-blockers See Container II:98, Antihypertensives
BOX II:100 Bioavailability, 1971, 1984-1991
BOX II:100 Biopharmaceutics, 1981, 1989
BOX II:100 Bioresearch Monitoring Program (BIMO), U.S. Food and Drug Administration
BOX II:100 Automatic Data Processing budget, 1983-1985
BOX II:100 Clinical Investigations Data File System, 1969, 1979-198-1983, 1999, undated
(3 folders)
BOX II:101 Clinical investigators form and clinical facilities file system, 1969-1975, 1999, undated
BOX II:101 General
BOX II:101 1971-1979
(7 folders)
BOX II:101 1980
(1 folder)
BOX II:102 (1 folder)
BOX II:102 1981-1982
(5 folders)
BOX II:102 1983
(1 folder)
BOX II:103 (1 folder)
BOX II:103 1984-1999, undated
(4 folders)
BOX II:103 Information Systems User Committee/BIMO Systems Task Group
BOX II:103 Chronology, 1979-1980
BOX II:103 General
BOX II:103 1977-1978
(2 folders)
BOX II:103 1979
(1 folder)
BOX II:104 (1 folder)
BOX II:104 1980-1982
(6 folders)
BOX II:105 1983, 1999
(4 folders)
BOX II:105 Presentation to BIMO Steering Committee, 1978, 1999
BOX II:105 Key events in National Center for Drugs and Biologics, circa 1981
BOX II:105 Meetings
BOX II:105 BIMO program managers
BOX II:105 1996
(5 folders)
BOX II:106 1997
(10 folders)
BOX II:106 Compliance Coordinating Committee, 1996
BOX II:106 Project Management Systems, implementation sessions
BOX II:106 1975-1980
(3 folders)
BOX II:107 1981-1983
(2 folders)
BOX II:107 Reports
BOX II:107 Annual, Fiscal Year 1980-Fiscal Year 1984
(5 folders)
Next Page »

Contents List